CTDP1

Across TCGA pan-cancer cohorts, CTDP1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CTDP1 data layer compared with 23 for mass-spec protein and 9 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CTDP1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated CTDP1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and GBM show a favorable association.

UCEC, GBM, and PDAC are the cancer types where CTDP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	II,III,IV	1.000	0.647	.017	16	view →
GBM	DFS	Quartile	All	0.537	0.193	.019	3	view →
PDAC	OS	Tertile	II,III,IV	0.865	0.777	.037	2	view →
HNSC	OS	Quartile	III,IV	0.768	0.982	.006	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CTDP1–UCEC (OS)

Open the UCEC breakdown →